Media Summary: First to identify destructive properties of Psoriasis is a chronic inflammatory skin disorder that affects about 2-3% of the population. It is triggered by the immune system, ... Join Dr Sofia Ramiro and Professors Iain McInnes, Atul Deodhar, and Laura Coates on our webinar hosted on the IMID Forum: ...

Pierre Miossec Targeting Il 17 - Detailed Analysis & Overview

First to identify destructive properties of Psoriasis is a chronic inflammatory skin disorder that affects about 2-3% of the population. It is triggered by the immune system, ... Join Dr Sofia Ramiro and Professors Iain McInnes, Atul Deodhar, and Laura Coates on our webinar hosted on the IMID Forum: ... Author video for 'Signalling of multiple interleukin (IL)-17 family cytokines via Join Dr Sofia Ramiro and Professors Atul Deodhar and Laura Coates as they discuss the recent webinar hosted on the IMID ... Dr. Tsoi discusses his research on the effects Ixekizumab and Guselkumab has on

Dr. Kantor talks with Dr. Tony Reder and answers the question, "Should I Have This video was created to be presented at the Grace Hopper Conference 2015. It showcases Franziska Seeger's work on the ...

Photo Gallery

Pierre Miossec: Targeting IL 17
Lecture of the DRFZ Albrecht Hasinger Lecturer 2021, Pierre Miossec
Perspectives in Inflammation – Prof Pierre Miossec
Psoriasis and beyond: targeting the IL-17 pathway
Pierre Miossec
Webinar: IL-17 Inhibition: Controlling inflammation and disease progression in SpA
IL-17 family cytokines involved in psoriasis, M.A.X. Tollenaere et al
Webinar Highlights Podcast: IL-17 Inhibition controlling inflammation and disease progression in SpA
lxekizumab Reduces key IL-17 and IL-23 Pathway Genes More Rapidly than Guselkumab | Lam Tsoi, PhD
Panel Discussion of IL 1 & IL 17
Family Matters: The Central Role of the IL-17 Family of Cytokines in Inflammatory Disease
Should I Have Interleukin 17 Tested
Sponsored
Sponsored
View Detailed Profile
Pierre Miossec: Targeting IL 17

Pierre Miossec: Targeting IL 17

Pierre Miossec

Lecture of the DRFZ Albrecht Hasinger Lecturer 2021, Pierre Miossec

Lecture of the DRFZ Albrecht Hasinger Lecturer 2021, Pierre Miossec

7.12.2021, DRFZ Prof.

Sponsored
Perspectives in Inflammation – Prof Pierre Miossec

Perspectives in Inflammation – Prof Pierre Miossec

First to identify destructive properties of

Psoriasis and beyond: targeting the IL-17 pathway

Psoriasis and beyond: targeting the IL-17 pathway

Psoriasis is a chronic inflammatory skin disorder that affects about 2-3% of the population. It is triggered by the immune system, ...

Pierre Miossec

Pierre Miossec

Pierre Miossec

Sponsored
Webinar: IL-17 Inhibition: Controlling inflammation and disease progression in SpA

Webinar: IL-17 Inhibition: Controlling inflammation and disease progression in SpA

Join Dr Sofia Ramiro and Professors Iain McInnes, Atul Deodhar, and Laura Coates on our webinar hosted on the IMID Forum: ...

IL-17 family cytokines involved in psoriasis, M.A.X. Tollenaere et al

IL-17 family cytokines involved in psoriasis, M.A.X. Tollenaere et al

Author video for 'Signalling of multiple interleukin (IL)-17 family cytokines via

Webinar Highlights Podcast: IL-17 Inhibition controlling inflammation and disease progression in SpA

Webinar Highlights Podcast: IL-17 Inhibition controlling inflammation and disease progression in SpA

Join Dr Sofia Ramiro and Professors Atul Deodhar and Laura Coates as they discuss the recent webinar hosted on the IMID ...

lxekizumab Reduces key IL-17 and IL-23 Pathway Genes More Rapidly than Guselkumab | Lam Tsoi, PhD

lxekizumab Reduces key IL-17 and IL-23 Pathway Genes More Rapidly than Guselkumab | Lam Tsoi, PhD

Dr. Tsoi discusses his research on the effects Ixekizumab and Guselkumab has on

Panel Discussion of IL 1 & IL 17

Panel Discussion of IL 1 & IL 17

Panel Discussion on IL 1 &

Family Matters: The Central Role of the IL-17 Family of Cytokines in Inflammatory Disease

Family Matters: The Central Role of the IL-17 Family of Cytokines in Inflammatory Disease

... that al-

Should I Have Interleukin 17 Tested

Should I Have Interleukin 17 Tested

Dr. Kantor talks with Dr. Tony Reder and answers the question, "Should I Have

Computationally designed IL-17 Cytokine Binders

Computationally designed IL-17 Cytokine Binders

This video was created to be presented at the Grace Hopper Conference 2015. It showcases Franziska Seeger's work on the ...